Risk factors and adverse perinatal outcomes among term and preterm infants born small-for-gestational-age: secondary analyses of the WHO multi-country survey on maternal and newborn health by Ota, E. et al.
PUBLISHED VERSION  
http://hdl.handle.net/2440/97173  
 
Erika Ota, Togoobaatar Ganchimeg, Naho Morisaki, Joshua P. Vogel, Cynthia Pileggi, Eduardo Ortiz-
Panozo, Joa, o P. Souza, Rintaro Mori, on behalf of the WHO Multi-Country Survey on Maternal and 
Newborn Health Research Network 
Risk factors and adverse perinatal outcomes among term and preterm infants born small-for-
gestational-age: secondary analyses of the WHO multi-country survey on maternal and newborn 
health 
PLoS One, 2014; 9(8):e105155-1-e105155-10 
© 2014 Ota et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited. 




























Risk Factors and Adverse Perinatal Outcomes among
Term and Preterm Infants Born Small-for-Gestational-
Age: Secondary Analyses of the WHO Multi-Country
Survey on Maternal and Newborn Health
Erika Ota1"*, Togoobaatar Ganchimeg1" , Naho Morisaki1,2, Joshua P. Vogel3,4, Cynthia Pileggi3,
Eduardo Ortiz-Panozo5, Joa˜o P. Souza5, Rintaro Mori1, on behalf of the WHO Multi-Country Survey on
Maternal and Newborn Health Research Network
1Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan, 2Department of Paediatrics, Graduate School of Medicine, University of
Tokyo, Tokyo, Japan, 3UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP),
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland, 4 School of Population Health, University of Western Australia, Perth,
Australia, 5Center for Population Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico
Abstract
Background: Small for gestational age (SGA) is not only a major indicator of perinatal mortality and morbidity, but also the
morbidity risks in later in life. We aim to estimate the association between the birth of SGA infants and the risk factors and
adverse perinatal outcomes among twenty-nine countries in Africa, Latin America, the Middle East and Asia in 359 health
facilities in 2010–11.
Methods: We analysed facility-based, cross-sectional data from the WHO Multi-country Survey on Maternal and Newborn
Health. We constructed multilevel logistic regression models with random effects for facilities and countries to estimate the
risk factors for SGA infants using country-specific birthweight reference standards in preterm and term delivery, and SGA’s
association with adverse perinatal outcomes. We compared the risks and adverse perinatal outcomes with appropriate for
gestational age (AGA) infants categorized by preterm and term delivery.
Results: A total of 295,829 singleton infants delivered were analysed. The overall prevalence of SGA was highest in
Cambodia (18.8%), Nepal (17.9%), the Occupied Palestinian Territory (16.1%), and Japan (16.0%), while the lowest was
observed in Afghanistan (4.8%), Uganda (6.6%) and Thailand (9.7%). The risk of preterm SGA infants was significantly higher
among nulliparous mothers and mothers with chronic hypertension and preeclampsia/eclampsia (aOR: 2.89; 95% CI: 2.55–
3.28) compared with AGA infants. Higher risks of term SGA were observed among sociodemographic factors and women
with preeclampsia/eclampsia, anaemia and other medical conditions. Multiparity (.= 3) (AOR: 0.88; 95% CI: 0.83–0.92) was a
protective factor for term SGA. The risk of perinatal mortality was significantly higher in preterm SGA deliveries in low to
high HDI countries.
Conclusion: Preterm SGA is associated with medical conditions related to preeclampsia, but not with sociodemographic
status. Term SGA is associated with sociodemographic status and various medical conditions.
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Introduction
Small for gestational age (SGA) refers to infants whose size and
weight is less than the average range for infants of the same
gestational age. GA is not only a major indicator of perinatal
mortality and morbidity [1,2], but also increases the risk of chronic
diseases such as cardiovascular disease and diabetes or develop-
mental outcomes later in life [3,4]. In a UK population-based cohort
study from 1997 to 2003, 43% of stillbirths were related to SGA [5].
Among 135 million infants born in low- and middle-income
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countries (LMICs) in 2010, it is estimated that 29.7 million (22%)
were born term-SGA, 10.9 million (8.1%) were born preterm
appropriate-for-gestational-age (AGA), and 2.8 million (2.1%) were
born preterm-SGA [6]. However, it is a great challenge to define
SGA in various ethnic groups in an international comparative study.
Based on the secondary analysis using 20 cohort studies for national
and regional estimates of SGA babies, 62% of SGA deliveries
occurred in India, and 56% occurred in Nepal [7]. This
overestimation arose due to the use of the Alexander reference in
the analysis, which adapted very high-income country group (US)
data from 1991 to low- and middle-income countries. The country-
specific birth reference was required to avoid an under- or
overestimate of SGA status, especially in low- and middle-income
countries. Birthweight references based on neonatal birthweight at
each gestational week have been used for nearly 50 years. This type
of reference is not so effective under diagnosis in the early gestational
weeks, especially for preterm SGA. Therefore, ultrasound-based
estimated references of fetal weight are more suitable to overcome
this problem. Mikolajczyk developed an ultrasound-based generic
global reference to measure fetal weight and birthweight in low-,
middle- and high-income settings [8]. Although this country-specific
reference has already been used in a previous study to define
macrosomia for international comparison [9], our study is the first to
use this global reference to define SGA for international compar-
ison.
The cause of SGA is multifactorial, and comprised of maternal,
placental, fetal or environmental factors. Identified maternal
factors of SGA include demographic variables and medical
conditions, such as maternal age [10,11], nulliparity [11,12],
cigarette smoking [12–15], short stature [12], caffeine intake [16],
low or high maternal body mass index (BMI) [10], hypertension
and preeclampsia [11,12,17], psychosocial stress [15], and
socioeconomic status, including education [14,17–20]. Conflicting
evidence exists for increased [21–23] or decreased [24,25], or
unchanged [26,27] neonatal mortality and morbidity rates for
preterm SGA compared with preterm AGA. Risk factors,
interventions and sequelae for preterm SGA might differ from
term SGA. Despite the high prevalence of SGA, only a limited
number of studies exist due to a lack of gestational age data,
especially in LMICs. Furthermore, few studies have considered
risk factors for SGA in preterm and term deliveries compared with
preterm AGA [10,23,28]. Therefore, we aimed to explore trends
and risk factors associated with SGA and its mortality in preterm
and term deliveries across multiple low- to very high- income
countries by taking advantage of the WHO Multi-country Survey
on Maternal and Newborn Health data, which covers 29 low- to
very high-income countries globally.
Methods
This is a secondary data analysis of the WHO Multi-country
Survey on Maternal and Newborn Health, which was conducted
in 359 health facilities across 29 countries in Africa, Asia, Latin
America and the Middle East. Methodological details of this
survey have been published elsewhere [29,30]. In brief, a
multistage cluster sampling method was used to obtain samples
of health facilities in two provinces and each capital city of the 29
randomly selected countries. All women admitted for delivery plus
all women with severe maternal outcomes regardless of gestational
age were recruited in the study. Individual data on demographics
and reproductive characteristics, medical conditions during
pregnancy, birth outcomes, and complications were collected
from the participants’ medical records. Health facility capacity
data were obtained, such as the capabilities of essential and
comprehensive obstetric and neonatal healthcare services, labora-
tory tests, and human resources and training. The study was
implemented concurrently in 29 countries over two to four months
from May 2010 to December 2012.
Study population and statistical analysis
The study population was restricted to pregnancies of at least 28
gestational weeks for comparability of viable gestational age
between countries, and singleton births with no congenital
malformation. We excluded deliveries with missing data on
birthweight, gestational age, and infant gender, as well as
pregnancies that lasted less than 22 weeks or more than 42 weeks
with congenital malformation.
To overcome the existing deficiency in birthweight references in
LMICs, and taking into account birthweight variations across
countries, we adopted methodology to generate local (country-
specific) fetal weight and birthweight references developed by
Mikolajczyk et al. [8].
To generate a country weight-reference standard, first we used
the mean birthweight for infants born to married mothers aged
20–34 years with schooling years $12, who had no pregnancy
complications, and who vaginally delivered singleton infants with
no complications at 40 completed weeks of gestation (40 weeks+
0 days to 40 weeks+6 days). Next, we based the birthweight (mean
and SD) reference on a gestational age of 40 weeks, and we
obtained the mean fetal-weight and percentiles across each
gestational week for all countries participating in this study. We
defined SGA as a birthweight below the 10th percentile, AGA as
between the 10th and 90th percentiles and large-for-gestational age
(LGA) as above the 90th percentile at the gestational ages of 28 to
41 weeks by infant gender. The study population was restricted to
deliveries with a birthweight below the 90th percentile, excluding
LGA due to the condition’s high risk of adverse birth outcomes.
We considered the following variables as exposures at the
individual level and further categorized them as shown in tables:
maternal age defined as completed years at the time of delivery;
marital status; years of education, parity; presence of chronic
hypertension, preeclampsia or eclampsia, severe anaemia with
haemoglobin ,7 mg/dl, malaria or dengue, HIV or AIDS and
other conditions defined as the presence of disease or injury
affecting the heart, lungs, liver and kidneys. Additionally, we
adjusted our analysis for facility capacity and the human
development index (HDI). Facility capacity was used in previous
studies and is defined as the total score of essential and additional
services provided by health facilities with further categorization
into high, medium and low capacity [31]. The human develop-
ment index (HDI) for each country was adopted from 2012 UN
development program estimates [32].
Perinatal outcomes considered in the study were fresh stillbirths
(excluding macerated stillbirths), early neonatal death, perinatal
death (both fresh stillbirth and early neonatal death) and neonatal
near miss [33]. Neonatal near miss is defined as a neonate who
survived a life-threatening condition and presented with any of the
following conditions: any intubation at birth or anytime within the
first week of life, nasal continuous positive airway pressure,
surfactant administration, cardiopulmonary resuscitation (cardiac
massage), any surgery, or use of any vasoactive drug, anticonvul-
sants, phototherapy in the first 24 hours, steroids to treat refractory
hypoglycaemia, or therapeutic intravenous antibiotics. Early
neonatal deaths were defined as intra-hospital deaths that
occurred on or before the seventh day after delivery.
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Statistical analysis
We divided our sample into two groups by gestational age:
preterm (,37 weeks gestational age) and term (37–41 weeks
gestational age) deliveries. The characteristics and outcomes of
SGA compared to AGA infants in these groups were analysed
separately. We compared preterm SGA vs preterm AGA, term
SGA vs term AGA.
We performed the Chi-square test by taking into account the
clustering and probability-sampling effects of the survey design.
Also, after considering the study sampling design and clustering
effects (health facility and country) on individual outcomes, we
constructed multilevel logistic regression models with random
effects for three levels: individual, facility and country. In our
analyses of the association between SGA and fresh stillbirths and
early neonatal death, we adjusted for maternal age, marital status,
education, parity, medical conditions during pregnancy such as
chronic hypertension, preeclampsia/eclampsia, severe anaemia,
malaria/dengue and HIV/AIDs at the individual level, and
capacity of health facilities at the facility level by four categorised
HDI groups. The categories comprised as follows: very high HDI
countries included Japan, Qatar and Argentina; high HDI
countries included Mexico, Lebanon, Peru, Brazil, Ecuador and
Sri Lanka; medium HDI countries included Jordan, China,
Thailand, Mongolia, the Occupied Palestinian Territory, Para-
guay, Philippines, Vietnam, Nicaragua, India and Cambodia, and
low HDI countries included Kenya, Pakistan, Angola, Nigeria,
Nepal, Uganda, Afghanistan, the Democratic Republic of Congo
and Niger. In the ‘overall category’, we adjusted three-level
structure random effects regression models to obtain odds ratios
(ORs): individual (level 1), facility (level 2) and country (level 3).
Statistical analysis was conducted using Stata/MP version 12.0
(Stata Corp LP, College Station, Texas) and a P-value,0.05 was
considered statistically significant.
Ethics committee approval
The HRP Specialist Panel on Epidemiological Research
reviewed and approved the study protocol for technical content.
This study was approved by the WHO Ethical Review Committee
and the relevant ethical clearance mechanisms in all countries.
Written consent from individual participants was not required,
although patient records was anonymized and de-identified prior
to analysis.
Results
The WHO Multi-country Survey on Maternal and Newborn
Health collected a total of 314,623 women’s data from 359 health
facilities in 29 countries. Excluded from the analysis were
deliveries with missing gestational age and birthweight (5,392),
pregnancies that lasted less than 28 weeks or more than 42 weeks
(6,191); multiple births (4,579), infants with congenital malforma-
tion (2,041) and missing infant gender (255). After the exclusions
were made, a total of 295,829 deliveries were retained in the
analysis. Table 1 presents the mean birthweight and the preva-
lence of SGA by each country. The overall prevalence of SGA was
highest in Cambodia (18.8%), Nepal (17.9%), the Occupied
Palestinian Territory (16.1%), and Japan (16.0%), while the lowest
was observed in Afghanistan (4.8%), Uganda (6.6%) and Thailand
(9.7%). With further exclusion of LGA infants, the sample size was
reduced to 245,77, consisting of 210,047 (85.5%) AGA and 35,726
(14.5%) SGA infants, including 3,827 (26.6%) preterm SGA and
31,932 (13.8%) term SGA, respectively. Table 2 indicates rates of
SGA by maternal and neonatal characteristics in preterm and
term deliveries. The rates of both preterm and term SGA
deliveries were consistently high across HDI groups.
Table 3 shows risk factors for SGA in preterm and term
deliveries. The risk factors of delivering preterm SGA infants were
significantly higher compared to AGA risk factors among
nulliparous women (adjusted odds ratio [AOR]: 1.17; 95% CI:
1.06–1.29), and women with chronic hypertension (AOR: 1.68;
95% CI: 1.22–2.30) and preeclampsia/eclampsia (AOR: 2.89;
95% CI: 2.55–3.28). Higher risks of term SGA compared with
term AGA were observed among younger (AOR: 1.09; 95% CI:
1.04–1.14) and older women (AOR: 1.07; 95% CI: 1.02–1.13),
single women (AOR: 1.11; 95% CI: 1.06–1.17), women with 1–6
years of education (AOR: 1.55; 95% CI: 1.46–1.65), nulliparous
women (AOR: 1.45; 95% CI: 1.41–1.50), and women with
preeclampsia/eclampsia (AOR: 2.05; 95% CI: 1.88–2.23), anae-
mia (HB,7 mg/dl) (AOR: 1.30; 95% CI: 1.15–1.47), HIV/AIDS
(AOR: 1.48; 95% CI: 1.22–1.80), and other medical conditions
(AOR: 1.47; 95% CI: 1.24–1.74). Multiparity (.=3) (AOR: 0.88;
95% CI: 0.83–0.92) was a protective factor for term SGA and,
after adjusting for variables, country HDI had no significant
association.
Prevalence of adverse perinatal outcomes for SGA by gesta-
tional weeks in each HDI country group is presented in Table 4.
We observed a significant trend of higher mortality rates in SGA
and all deliveries for lower HDI countries (P,0.001).
The association between SGA deliveries and fresh stillbirths,
neonatal near miss, early neonatal deaths, and perinatal deaths
compared with AGA deliveries by HDI country group are
presented in Table 5 and are stratified by preterm and term
delivery. For preterm and term SGA, very high HDI countries had
no significant increase in fresh stillbirth, early neonatal mortality
and perinatal mortality, although low to high HDI countries had
risks two to four times higher than preterm AGA. For neonatal
near miss, both preterm and term SGA deliveries had 1.7 to 2.7
times significantly higher risk than AGA, although preterm SGA
had a higher prevalence of near miss (50% to 80% among
neonates of less than 32 weeks’ gestation) than term SGA,
irrespective of HDI countries.
Discussion
Main findings
We determined the maternal risk factors and adverse perinatal
outcomes in preterm- and term-SGA infants in 29 countries
globally using a large multi-country dataset. After adjusting for
country-, facility- and individual-level effects, we found no
association between increased risks of preterm SGA and socio-
demographic status, such as age or education, compared with
preterm AGA; however, we did observe that nulliparity and
medical conditions, such as chronic hypertension and preeclamp-
sia/eclampsia, were significantly associated with increased risks of
preterm SGA compared with preterm AGA.
Strengths and limitations
To the best of our knowledge, this is the most current and
extensive multi-country study to compare and examine risk factors
and their adverse outcomes in preterm SGA and term SGA
deliveries compared with preterm and term AGA deliveries using
country-specific generic references. We used SGA criteria that
incorporates country-specific reference standards developed by
Mikolajczyk et al. [8]. This generic, global reference for fetal-
weight and birthweight percentiles is more effective in predicting
adverse perinatal outcomes compared with non-customised fetal-
weight references, and is easier to use than the customised fetal-
Risk Factors for Small-for-Gestational-Age Infants
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weight reference. A large sample size and the use of standardized
questionnaires across countries allowed us to examine outcomes
and stratify countries by five HDI groups.
Our study has several limitations. First, the quality of the data,
especially birthweight and gestational age, is questionable in some
countries. Errors might occur in dating the pregnancy, especially
in countries where gestational age is based on the last menstrual
Table 2. Maternal and neonatal characteristics.
Preterm delivery (#36 weeks) p value Term delivery ($37 weeks) p value
Total deliveries SGA [n (%)] Total deliveries SGA [n (%)]
All deliveries 14,360 3,827 (26.6) 231,413 31,899(13.8)
Age
,20 1,840 530 (28.8) p,0.05 25,283 4,508 (17.8) p,0.001
20–34 10,608 2,753 (25.9) 179,550 24,132 (13.4)
$35- 1,912 544 (28.4) 26,580 3,292 (12.3)
Marital status
Single 1,684 520 (30.8) p,0.01 24,077 4,122 (17.1) p,0.001
Married 12,570 3,277 (26.1) 205,625 27,585 (13.4)
Education, years
0 1,936 485 (25.0) 0.466 34,276 4,163 (12.1) p,0.001
1–6 1,948 501 (25.7) 30,242 4,850 (16.0)
7–9 2,988 776 (25.9) 44,161 6,386 (14.5)
10–12 4,234 1,176 (27.8) 67,652 9,852 (14.6)
.12 2,082 584 (28.1) 37,896 4,641 (12.2)
Parity
0 6,766 1,889 (27.9) p,0.05 102,653 16,831 (16.4) p,0.001
1–2 5,617 1,420 (25.3) 93,762 11,354 (12.1)
$3 1,958 511 (26.1) 34,696 3,681 (10.6)
Mode of delivery
Vaginal 8,801 2,109 (23.9) p,0.001 169,114 23,157 (13.7) 0.298
Caesarean 5,538 1,708 (30.8) 62,022 8,709 (14.0)
Medical conditions
Chronic hypertension 228 96 (42.1) p,0.001 703 134 (19.1) p,0.001
Pre-/eclampsia 1,680 781 (46.5) p,0.001 4,207 1,031 (24.5) p,0.001
Anaemia (HB,7 mg/dl) 608 210 (34.5) p,0.01 2,791 512 (18.3) p,0.001
Malaria/dengue 55 17 (30.9) 0.540 193 46 (23.8) p,0.001
HIV/AIDs 99 26 (26.3) 0.935 845 161 (19.1) p,0.001
Others 318 115 (36.2) p,0.01 1,221 218 (17.8) p,0.001
Infant gender
Male 7,605 1,994 (26.2) 0.248 118,483 15,856 (13.4) p,0.001
Female 6,755 1,833 (27.1) 112,930 16,043 (14.2)
Apgar score at
5 minutes ,7
1,253 502 (40.1) p,0.001 4,503 1051 (23.3) p,0.001
Country HDI
Very high 768 209 (27.2) p,0.001 13,725 1,993 (14.5) p,0.05
High 3,736 1,173 (31.4) 51,470 7,548 (14.7)
Medium 5,443 1,239 (22.8) 76,203 10,938 (14.4)
Low 4,13 1,206 (27.3) 90,015 11,420 (12.7)
Facility capacity
High 5,053 1,390 (27.5) 0.245 60,857 8,435 (13.8) 0.119
Medium 5,349 1,470 (27.5) 92,575 11,970 (12.9)
Low 2,552 596 (23.4) 48,288 7,274 (15.1)
Other medical conditions were included, such as chronic or acute injury or disorders affecting the heart, lungs, liver and kidneys (including pyelonephritis).
Chi-square p-values adjusted for survey design.
doi:10.1371/journal.pone.0105155.t002
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period or where the birthweight is rounded up or down by a full
100 g. Due to this limitation, we focused on identifying the risk
factors of SGA rather than focusing on SGA prevalence in each
country.
Another limitation is a lack of data on maternal characteristics
that have been noted in previous studies to be associated with the
delivery of SGA infants, including smoking, alcohol and caffeine
intake, maternal BMI, malnutrition, gestational weight gain,
maternal stature, psychosocial stress, interpregnancy interval,
and previous history of miscarriage [10–16]. Lack of adjustment
for these variables may have led to an overestimation of the risk of
SGA delivery, especially for women of a younger or older age,
with less education or in low HDI-scoring countries.
Lastly, by using multilevel multiple regression analysis we were
able to generalize our findings among facility-based settings;
however, adverse perinatal outcomes and maternal medical
conditions may have been overestimated because only the most
severe cases are presented in higher-level facilities. Furthermore,
the risk of neonatal mortality and morbidity could be underesti-
mated due to the 7-day period in this study for neonatal follow-up.
It should be noted that mortality due to infections, necrotising
enterocolitis and other complications may occur after this period.
Thus, the outcomes and conditions cannot be considered
representative of the general population.
Interpretation
Our results suggest that nulliparity, chronic hypertension and
preeclampsia/eclampsia are associated with a higher risk of
preterm SGA. This result is consistent with other studies [18,34].
In a national birth cohort study in Denmark, Catov et al. found
that risk of preterm SGA increased 5.5 (95% confidence interval
[CI] 3.2–9.4) times and term SGA increased 1.5 (95% CI 1.0–2.2)
times among women with chronic hypertension [34]. The result is
also consistent with the findings of Villar et al. who analysed data
Table 3. Risk factors for SGA.
Preterm delivery (#36 weeks) Term delivery ($37 weeks)
OR AOR 95% CI OR AOR 95% CI
Age
,20 1.15* 1.04 (0.89–1.20) 1.39*** 1.09 (1.04–1.14)***
20–34 reference
$35- 1.13* 1.08 (0.94–1.24) 0.91** 1.07 (1.02–1.13)**
Marital status
Single 1.27** 1.15 (0.98–1.34) 1.33*** 1.11 (1.06–1.17)***
Married reference
Education, years
0 0.85 1.07 (0.88–1.31) 0.99 1.50 (1.41–1.61)***
1–6 0.88 1.03 (0.86–1.23) 1.37*** 1.55 (1.46–1.65)***
7–9 0.89 1.01 (0.86–1.19) 1.21*** 1.34 (1.27–1.41)***
10–12 0.98 1.02 (0.89–1.18) 1.22*** 1.22 (1.17–1.28)***
.12 reference
Parity
0 1.14** 1.17 (1.06–1.29)** 1.42*** 1.45 (1.41–1.50)***
1–2 reference
$3 1.04 0.96 (0.83–1.12) 0.86*** 0.88 (0.83–0.92)***
Medical conditions
Chronic hypertension 2.02*** 1.68 (1.22–2.30)** 1.47*** 1.20 (0.96–1.49)
Preeclampsia/eclampsia 2.75*** 2.89 (2.55–3.28)*** 2.06*** 2.05 (1.88–2.23)***
Anaemia (HB,7 mg/dl) 1.48*** 1.24 (0.99–1.56) 1.41*** 1.30 (1.15–1.47)***
Malaria/dengue 1.23 1.16 (0.58–2.32) 1.96*** 1.26 (0.83–1.92)
HIV/AIDs 0.98 0.85 (0.50–1.44) 1.47*** 1.48 (1.22–1.80)***
Others medical
conditions
1.58** 1.24 (0.92–1.67) 1.36** 1.47 (1.24–1.74)***
Country HDI
Very high reference
High 1.22 1.23 (0.64–2.34) 1.01 0.79 (0.39–1.59)
Medium 0.78* 0.88 (0.47–1.63) 0.98 0.85 (0.51–1.44)
Low 1.01 1.28 (0.68–2.42) 0.85* 0.61 (0.37–1.02)
Other medical conditions were included, such as chronic or acute injury or disorders affecting the heart, lungs, liver and kidneys (including pyelonephritis).
SGA= small-for-gestational age; HDI =Human Development Index; OR = odds ratio; AOR = adjusted odds ratio. Three-level structure random effects regression models
were used to obtain ORs: individual (level 1), facility (level 2) and country (level 3).
***p,0.001 **p,0.01 *p,0.05.
doi:10.1371/journal.pone.0105155.t003
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from WHO antenatal care trials and observed that nulliparity,
chronic hypertension and obesity are also risk factors for
preeclampsia in developing countries, but not low socioeconomic
status [18]. Preeclampsia may cause an inadequate vascular
response to abnormal placentation in pregnancy and may
represent a distinct pathogenesis, which might affect fetal growth
[6,35]. Increased risk screening in antenatal care visits and referral
to higher facilities for high-risk cases at an earlier stage in the
pregnancy may help to reduce the incidence of severe preeclamp-
sia or eclampsia.
We found that sociodemographic factors such as age, marital
status and education were not significantly associated with the risk
of preterm SGA, but sociodemographic status factors were related
to term SGA. The results indicated that preterm SGA deliveries
are more likely to be related to a maternal medical condition,
especially preeclampsia, which tends to terminate the pregnancy
earlier. On the other hand, term SGA may be more significantly
relevant to lifestyle factors, such as sociodemographic status,
malnutrition or other factors, and various medical conditions such
as anaemia, HIV/AIDS and others. Our results are consistent
with other studies that have observed a significant increased risk of
term SGA associated with maternal age [10,11] and nulliparity
[11,12]. Previous studies confirm that sociodemographic status is
associated with a greater risk of SGA, although these studies did
not divide SGA by preterm and term delivery [15,36]. Berg et al.
conducted path analysis to examine the relationship between
maternal education and SGA using population-based cohort study
data and showed that a significantly increased risk of SGA delivery
among women with less education was related foremost to
maternal smoking and, to some degree, to maternal height [15].
A population-based case-control study using Finnish birth register
data also confirmed that between high and low socioeconomic
status groups, 50% of the difference in risk of SGA was due to
smoking [36].
Very high HDI countries showed no significant increase in the
mortality risk for preterm and term SGA deliveries. This might be
explained by the high quality of intrapartum care including access
to care, human resources and drugs or medical equipment in very
high HDI countries, which could reduce the mortality risk for
preterm and term SGA deliveries. However, low to high HDI
countries had risks two to four times higher compared to preterm
AGA. These results are consistent with the population-based
secondary analysis conducted in 20 cohorts in LMICs by the Child
Health Epidemiology Reference Group (CHERG), which showed
that the risk of early neonatal mortality increased about 16 times
for preterm SGA delivery compared with preterm non-SGA
delivery [37]. The reason for these different degrees of mortality
risk might be due to the definition of SGA used by the authors,
which they adapted from the US population birthweight reference
standard and applied to LMICs. Another population-based cohort
study in France showed that the risk of stillbirth was 2.6 times
higher in preterm SGA deliveries, which is a similar result to our
Table 4. Prevalence of fresh stillbirths and early neonatal mortality by HDI country groups.
Outcome SGA [n/N (%)] HDI country group [n/N (%)] p-value
Very High High Medium Low
Fresh stillbirth
All deliveries 2458/244382 (1.0) 31/14426 (0.2) 183/55096 (0.3) 578/81251 (0.7) 1666/93578 (1.8) p,0.001
SGA deliveries
#32 144/797 (18.1) 3/44 (6.8) 20/248(8.1) 41/243 (16.9) 80/262 (30.5) p,0.001
33–36 169/2748 (6.2) 3/160 (1.9) 27/890 (3.0) 55/920 (6.0) 84/778 (10.8) p,0.001
$37 520/31585 (1.7) 3/1987 (0.2) 31/7529 (0.4) 133/10837 (1.2) 353/11232 (3.1) p,0.001
Neonatal near miss
All live deliveries 11436/228831 (4.8) 454/14417 (3.2) 3210/54736 (5.9) 4550/80108 (5.7) 3222/91006 (3.5) p,0.001
SGA deliveries
#32 355/484 (73.4) 32/40 (80.0) 160/201 (79.6) 115/145 (79.3) 48/98 (49.0) p = 0.003
33–36 1011/2419 (41.8) 49/155 (31.6) 396/837 (47.3) 358/801 (44.7) 208/626 (33.2) p = 0.019
$37 1889/30785 (6.1) 58/1982 (2.9) 441/7480 (5.9) 826/10603 (7.8) 564/10720 (5.3) p = 0.016
Early neonatal death
All live deliveries 1534/241924 (0.6) 19/14426 (0.1) 160/54913 (0.3) 514/80673 (0.6) 841/91912 (0.9) p,0.001
SGA deliveries
#32 162/653 (24.8) 1/41 (2.4) 23/228 (10.1) 56/202 (27.7) 82/182 (45.1) p,0.001
33–36 152/2579 (5.9) 2/157(1.3) 23/863 (2.7) 61/865 (7.1) 66/694 (9.5) p,0.001
$37 267/31065 (0.9) 3/1984 (0.2) 15/7498 (0.2) 93/10704 (0.9) 156/10879 (1.4) p,0.001
Perinatal death
All deliveries 3992/244382 (1.6) 50/14457 (0.4) 343/55096 (0.6) 1092/81251 (1.3) 2507/93578 (2.7) p,0.001
SGA deliveries
#32 306/797 (38.4) 4/44 (9.9) 43/248 (17.3) 97/243 (39.9) 162/262 (61.8) p,0.001
33–36 321/2748 (11.7) 5/160 (3.1) 50/890 (5.6) 116/920 (12.6) 150/778 (19.3) p,0.001
$37 787/31585 (2.5) 6/1987 (0.3) 46/7529 (0.6) 226/10837 (2.1) 509/11232 (4.5) p,0.001
SGA= small-for-gestational age; HDI =Human Development Index Chi-square p-values adjusted for survey design.
doi:10.1371/journal.pone.0105155.t004
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overall mortality risks [38]. Simchen et al. found that singleton
preterm SGA infants had a significantly higher mortality rate with
more culture-proven sepsis episodes [23].
In our findings, the risk of mortality in both preterm and term
SGA deliveries was higher compared to preterm and term AGA,
respectively, in low to high HDI countries. However, very high
HDI countries had no significant mortality difference between
preterm SGA and AGA, but had higher risks of mortality for term
SGA, especially in fresh stillbirths.
Our findings indicate that if LMICs give appropriate care
comparable with very high HDI countries, such as including
regular risk screening in antenatal care visits and providing
adequate treatment and care to those who need treatment at an
earlier stage, it might be possible to decrease perinatal mortality
among preterm SGA infants. Term SGA infants were three to four
times significantly more likely to experience perinatal mortality
than term AGA infants, irrespective of HDI groups. This finding
supports Lubchenco’s report from 1976, which found that the risk
of neonatal mortality was six times more likely in term SGA infants
compared with term AGA infants [39]. Risk of perinatal mortality
is significantly higher among term SGA deliveries compared with
preterm AGA deliveries, irrespective of quality of care.
Neonatal near miss is higher risk, irrespective of HDI, although
it has a high prevalence in neonates born at less than 32 weeks’
gestation. In very high HDI countries, 80% of neonates born at
less than 32 gestational weeks experienced neonatal near miss,
although perinatal mortality was around 11%. In low HDI
countries, 49% of neonates born at less than 32 gestational weeks
experienced neonatal near miss, and 70% of them died. The
quality of neonatal intensive care is vital to prevent mortality.
Neonatal clinical management should be considered in the
development of health policies for reducing neonatal mortality,
such as screening high-risk neonates for early complications and
the referral of pregnant women with hypertensive diseases for
delivery in health facilities with special care units. Careful follow-
up is necessary for SGA neonates who are at a higher risk of
acquiring non-communicable diseases in the future.
Further research could define SGA using the customized rather
than standard intrauterine growth curves, especially for countries
that adopt curves based on populations from diverse ethnic
Table 5. The association between SGA and perinatal outcomes compared with AGA by HDI country groups.
HDI group Preterm delivery (#36 weeks) Term delivery ($37 weeks) All deliveries
AOR 95% CI AOR 95% CI AOR 95% CI
Fresh stillbirth
Very high 0.31 (0.06–1.76) 1.79 (0.29–10.9) 1.46 (0.47–4.51
High 2.31 (1.36–3.93)** 3.00 (1.75–5.12)*** 3.70 (2.56–5.33)***
Medium 2.18 (1.62–2.96)*** 3.08 (2.43–3.89)*** 2.97 (2.47–3.56)***
Low 1.99 (1.54–2.57)*** 2.89 (2.47–3.37)*** 3.07 (2.69–3.51)***
Overall1 2.01 (1.66–2.42)*** 2.95 (2.60–3.36)*** 3.07 (2.77–3.41)***
Neonatal near miss
Very high 2.34 (1.47–3.71)*** 1.65 (1.13–2.42)** 2.61 (2.02–3.37)***
High 2.60 (2.17–3.11)*** 1.69 (1.48–1.93)*** 2.47 (2.24–2.71)***
Medium 2.32 (1.98–2.74)*** 2.38 (2.17–2.61)*** 2.43 (2.26–2.63)***
Low 2.43 (1.97–2.99)*** 1.75 (1.57–1.95)*** 2.03 (1.85–2.23)***
Overall1 2.65 (2.37–2.96)*** 1.99 (1.87–2.12)** 2.39 (2.27–2.51)***
Early neonatal death
Very high 1.19 (0.25–5.74) 1.39 (0.15–12.32) 2.14 (0.67–6.94)
High 3.77 (1.97–6.47)*** 2.14 (1.09–4.20)* 3.92 (2.57–5.97)***
Medium 2.77 (2.08–3.68)*** 3.44 (2.61–4.56)*** 3.56 (2.93–4.32)***
Low 2.92 (2.21–3.83)*** 2.94 (2.37–3.63)*** 3.53 (3.00–4.16)***
Overall1 2.86 (2.36–3.46)*** 3.01 (2.56–3.56)*** 3.52 (3.12–3.96)***
Perinatal death
Very high 0.69 (0.22–2.16) 1.78 (0.46–6.82) 1.76 (0.78–3.99)
High 2.89 (1.94–4.31)*** 2.63 (1.73–3.99)*** 3.80 (2.88–5.02)***
Medium 2.61 (2.10–3.25)*** 3.27 (2.72–3.92)*** 3.29 (2.88–7.77)***
Low 2.51 (2.06–3.06)*** 2.92 (2.58–3.32)*** 3.31 (2.98–3.67)***
Overall1 2.50 (2.17–2.87)*** 3.00 (2.71–3.32)*** 3.31 (3.06–3.59)***
The reference category is infants with a birthweight that is appropriate for gestational age in each subgroup analysis.
SGA= small-for-gestational age; AGA= appropriate-for-gestational age; HDI =Human Development Index, AOR= adjusted odds ratio.
Two-level structure random effects regression models were used to obtain ORs: individual (level 1) and facility (level 2). Adjusted for maternal age, marital status,
education, parity, medical conditions during pregnancy such as chronic hypertension, preeclampsia/eclampsia, severe anaemia, malaria/dengue, HIV/AIDs at the
individual level, and capacity of health facilities at the facility level.
1Three-level structure random effects regression models were used to obtain ORs: individual (level 1), facility (level 2) and country (level 3). Same adjustment at
individual and facility level and additional adjustment for country HDI at the country level.
***p,0.001 **p,0.01 *p,0.05.
doi:10.1371/journal.pone.0105155.t005
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groups. Ideally the standard questionnaire should include variables
such as weight gain during pregnancy and pre-pregnancy BMI.
Conclusion
Our results demonstrate that preterm SGA is associated with
medical conditions related to chronic hypertension and pre-
eclampsia/eclampsia, but is not associated with sociodemographic
status. This result clearly identified that global prevention for
preterm SGA should mainly focus on preeclampsia. Term SGA is
associated with sociodemographic status and various medical
conditions. Risk of fresh stillbirth and neonatal death was two to
three times higher in preterm SGA in LMICs, except in the very
high HDI group. Term SGA was significantly associated with
perinatal deaths irrespective of HDI categories.
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